Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Sir Peter Ratcliffe is one of the co-founders of the Phenomics Discovery initiative (PDi), which will be housed in the Target Discovery Institute. The PDi aims to build robust disease-relevant phenotypic assays to help identify new drug targets.